IFNGR1 and neoplasm: Together these data suggest that IFNγR signaling mediates the induction of Qa-1b on tumor cells, leading to the engagement of the NKG2A/CD94 receptor on CAR-T cells and subsequent inhibition of CAR-T efficacy.